LSL Pharma Group Inc. (TSXV:LSL)

Canada flag Canada · Delayed Price · Currency is CAD
0.5200
0.00 (0.00%)
At close: Feb 9, 2026
Market Cap63.03M +39.9%
Revenue (ttm)26.80M +69.4%
Net Income2.78M
EPS0.02
Shares Out121.22M
PE Ratio22.92
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume24,000
Average Volume60,765
Open0.5300
Previous Close0.5200
Day's Range0.5200 - 0.5300
52-Week Range0.2900 - 0.5600
Beta-0.35
RSI64.65
Earnings DateFeb 27, 2026

About LSL Pharma Group

LSL Pharma Group Inc. develops, manufactures, and commercializes sterile pharmaceutical products, cosmetic products, and natural health products in Canada, the United States, and internationally. The company offers dietary supplements and vitamins in the tablet and capsule form; niche sterile ophthalmic products in the form of ointments and drops; and cosmetic, pharmaceutical, and natural health products in liquid and semi-solid form for pharmacy banners and hospitals. The company is headquartered in Boucherville, Canada. [Read more]

Sector Healthcare
CEO Francois Roberge
Employees 185
Stock Exchange TSX Venture Exchange
Ticker Symbol LSL
Full Company Profile

Financial Performance

Financial Statements